These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9310272)

  • 21. Calf blood flow in intermittent claudication.
    Jacobs S; Reich T
    Arch Surg; 1975 Dec; 110(12):1465-8. PubMed ID: 1200831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of intravenous lipoprostaglandin E1 on neurogenic intermittent claudication.
    Murakami M; Takahashi K; Sekikawa T; Yasuhara K; Yamagata M; Moriya H
    J Spinal Disord; 1997 Dec; 10(6):499-504. PubMed ID: 9438815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of prostaglandin E1, dobutamine and placebo on hemodynamic, renal and neurohumoral variables in patients with advanced heart failure.
    Wimmer A; Stanek B; Kubecova L; Vitovec J; Spinar J; Yilmaz N; Kos T; Hartter E; Frey B; Pacher R
    Jpn Heart J; 1999 May; 40(3):321-34. PubMed ID: 10506854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement of peripheral and cardiopulmonary performance after a short-term exercise program with additive prostaglandin E1.
    Cachovan M; Rogatti W
    Angiology; 2001 Jun; 52(6):381-91. PubMed ID: 11437028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of regular physical training in a supervised class and additional intravenous prostaglandin E1 and naftidrofuryl infusion therapy in patients with intermittent claudication--a controlled study.
    Diehm C; Kühn A; Strauss R; Hübsch-Müller C; Kübler W
    Vasa Suppl; 1989; 28():26-30. PubMed ID: 2609241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Rehabilitation program in patients with moderate-to-severe intermittent claudication: immediate results and one year follow-up].
    Rossini D; Bulckaen M; Di Marco S; Giovannetti R; Giuntoli F; Lacopetti L; Vergoni W
    Monaldi Arch Chest Dis; 2007 Jun; 68(2):110-4. PubMed ID: 17886772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of prostaglandin E1 infusion in severe chronic heart failure.
    Pacher R; Stanek B; Hülsmann M; Sinzinger H
    Prostaglandins; 1997 Apr; 53(4):221-35. PubMed ID: 9167210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired cholinergic peripheral vasodilation and its relationship to hyperemic calf blood flow response and exercise intolerance in patients with chronic heart failure.
    Nakamura M; Chiba M; Ueshima K; Arakawa N; Yoshida H; Makita S; Funakoshi T; Hashimoto K; Ishikawa M; Hiramori K
    Int J Cardiol; 1995 Feb; 48(2):139-46. PubMed ID: 7774992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of glutathione infusion on leg arterial circulation, cutaneous microcirculation, and pain-free walking distance in patients with peripheral obstructive arterial disease: a randomized, double-blind, placebo-controlled trial.
    Arosio E; De Marchi S; Zannoni M; Prior M; Lechi A
    Mayo Clin Proc; 2002 Aug; 77(8):754-9. PubMed ID: 12173710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of canine infarct size by bolus intravenous administration of liposomal prostaglandin E1: comparison with control, placebo liposomes, and continuous intravenous infusion of prostaglandin E1.
    Feld S; Li G; Wu A; Felli P; Amirian J; Vaughn WK; Gornet T; Swenson C; Smalling RW
    Am Heart J; 1996 Oct; 132(4):747-57. PubMed ID: 8831361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prostaglandin E1 in the treatment of chronic ischemia of the extremities].
    Kowal-Gierczak B; Kurzawska-Mielecka M; Czarnacki M
    Pol Arch Med Wewn; 1990 Nov; 84(5):321-7. PubMed ID: 2075125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beneficial effects of a serine protease inhibitor in peripheral vascular disease.
    Urabe Y; Ideishi M; Sasaguri M; Ikeda M; Arakawa K
    Am J Cardiol; 1993 Jul; 72(2):218-22. PubMed ID: 8328387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of prostaglandin E1 on renal haemodynamics in a patient with diabetic nephropathy.
    Okada S; Ogino Y; Ichiki K; Tanokuchi S; Ishii K; Hamada H; Ota Z; Hiraki Y
    J Int Med Res; 1991; 19(6):497-500. PubMed ID: 1773911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of a 4-week treatment with prostaglandin E1 on health-related quality of life of patients with intermittent claudication.
    Mangiafico RA; Messina R; Attinà T; Dell'Arte S; Giuliano L; Malatino LS
    Angiology; 2000 Jun; 51(6):441-9. PubMed ID: 10870853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral oxygenation during prostaglandin E1 induced hypotension.
    Kadoi Y; Saito S; Kunimoto F; Morita T; Goto F; Kawahara F; Fujita N
    Can J Anaesth; 1998 Sep; 45(9):860-4. PubMed ID: 9818109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of groin incision, duration of ischemia, and prostaglandin E1 on ischemia-reperfusion injury of the lower limb.
    Frässdorf J; Luther B; Müllenheim J; Otto F; Preckel B; Schlack W; Thämer V
    J Cardiothorac Vasc Anesth; 2006 Apr; 20(2):187-95. PubMed ID: 16616658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of exogenous adenosine and voluntary exercise on human skeletal muscle perfusion and perfusion heterogeneity.
    Heinonen I; Kemppainen J; Kaskinoro K; Peltonen JE; Borra R; Lindroos MM; Oikonen V; Nuutila P; Knuuti J; Hellsten Y; Boushel R; Kalliokoski KK
    J Appl Physiol (1985); 2010 Feb; 108(2):378-86. PubMed ID: 19940098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis of costs and results of prostaglandin (PGE1 alpha-cyclodestrin) therapy of peripheral arterial diseases].
    Bucci M; Iacobitti P; Laurora G; Cesarone MR
    Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):9-15. PubMed ID: 10658439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effectiveness of pentoxifylline and of bio-electromagnetic therapy in lower limb obliterative arterial disease].
    Bernát SI
    Orv Hetil; 2013 Oct; 154(42):1674-9. PubMed ID: 24121220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iontophoretic application of prostaglandin E1 for improvement in peripheral microcirculation.
    Saeki S; Yamamura K; Matsushita M; Nishikimi N; Sakurai T; Nimura Y
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):525-9. PubMed ID: 9799055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.